In vivo administration of interleukin-2.
In vivo administration of interleukin-2.
复制标题
IL-2的体内给药。
DOI:
10.1007/978-1-4684-4838-2_11
复制
发表时间:
1985
期刊:
影响因子:
--
通讯作者:
Greenberg,PD
中科院分区:
文献类型:
--
作者:
Cheever,MA;Greenberg,PD
Interleukin-2 (IL-2), also known as T-cell growth factor (TCGF), induces the replication of antigen-activated T cells in vitro. However, little is known concerning its function in vivo as a pharmacologic agent. The purpose of this chapter is to review evidence from animal models that IL-2 administered in vivo can induce T-cell growth in vivo and thereby augment specific T-cell immunity. In addition, an attempt is made to identify clinical immunodeficiency states in which the administration of IL-2 might be therapeutic; some of the potential toxicities of IL-2 and effects on immunity that might limit its use as a systemic reagent are discussed.In vitro studies have provided much information about the biology and function of IL-2 as a T-cell proliferative signal; this work forms the theoretical basis for predicting its potential uses in vivo. In vitro cell-mediated immune reactions result from a complex series of interactions among antigen, antigen-reactive cells, and secreted factors (reviewed in Oppenheim and Gery, 1982). Macrophages process antigen and present it to T lymphocytes, in addition to producing an essential lymphocyte-activating factor, Interleukin-1 (IL-1)(Smith et al., 1980). The specific binding of antigen to T cells bearing clonally distributed antigen receptors provides the first signal for T-cell proliferation and results in the expression of membrane receptors for IL-2 (Smith et al., 1979; Bonnard et al., 1979; Robb et al., 1981). A subset of T cells, functionally defined as amplifier T cells, synthesizes and secretes IL-2, but only after specific activation by antigen and stimulation by the macrophage-produced IL-1. The binding ofIL-2 to its receptor
登录
查看更多内容
影响因子:
64.8
作者:
H. Wagner;C. Hardt;K. Heeg;M. Röllinghoff;K. Pfizenmaier
通讯作者:
K. Pfizenmaier
影响因子:
4.4
作者:
O. Kanagawa;J. Louis;H. Engers;J. Cerottini
通讯作者:
J. Cerottini
影响因子:
--
作者:
M. Nabholz;H. Engers;D. Collavo;M. North
通讯作者:
M. North
影响因子:
15.3
作者:
C. Hardt;M. Rollinghoff;K. Pfizenmaier;H. Mosmann;H. Wagner
通讯作者:
H. Wagner
DOI:
10.4049/jimmunol.123.4.1632
发表时间:
1979
期刊:
The Journal of Immunology
影响因子:
--
作者:
S. Gillis;G. Crabtree;Kendall A. Smith
通讯作者:
Kendall A. Smith